Clinical, biochemical profile and atherosclerotic cardiovascular risk score (ASCVD) in patients with high HDL cholesterol

被引:0
作者
Mallya, Raksha Udupi [1 ]
Vidyasagar, Sudha [1 ]
Varashree, B. S. [2 ]
Sukumar, Cynthia Amrutha [1 ]
机构
[1] Manipal Acad Higher Educ, Kasturba Med Coll, Dept Gen Med, Manipal 576104, Karnataka, India
[2] Manipal Acad Higher Educ, Kasturba Med Coll, Dept Biochem, Manipal 576104, Karnataka, India
关键词
ASCVD; CETP; HDL cholesterol; Lipidology; METs; CORONARY-HEART-DISEASE; ALCOHOL-CONSUMPTION; ATHEROGENIC DYSLIPIDEMIA; HYPERTENSION; POPULATION; JAPANESE; GENE;
D O I
10.1007/s11845-025-03878-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundIt was observed that many people in the western coastal belt were found to have a high HDL cholesterol, the cause of which was not known. This study was done to learn about the factors contributing to the high HDL cholesterol in these patients and its effect on ASCVD risk.MethodsIn this prospective, case control study, 150 patients were recruited, of which 63 were cases (patients with high HDL cholesterol), and 87 were controls (patients with normal HDL cholesterol). Details regarding their diet, sea-food consumption, habits, comorbidities, daily activity (using GPAQ questionnaire), and blood reports were collected. ASCVD risk score was calculated using an online ASCVD risk estimator. Blood samples of 96 patients (cases 40, controls 56) was tested for cholesterol esterase transfer protein (CETP) levels using ELISA, and the results were compared.ResultsPatients with high HDL cholesterol were found to be physically more active and had median metabolic equivalent (METs) of 4680 (1200, 8580) compared with controls with median METs of 1680 (720, 5580), P-0.013. Cases had a lower mean BMI 23.09(SD-3.69), than in patients with normal HDL cholesterol with a mean of 24.41(SD-4.01), P-0.04. Cases also had a lower triglyceride level (91(69,118) in cases vs 121 (80,151) in controls, P-0.002. Alcohol and sea food consumption had no role on HDL levels in this study. The median CETP level was lower in patients with high HDL levels, 0.336(0.08, 0.336) versus 1.435(0.061, 2.893) in the control group although not statistically significant. Patients with high HDL cholesterol were found to have a significantly lower median 10-year ASCVD risk score 3.05 (0.6, 8.95), compared with patients with normal HDL 6.45 (2.7,14.2).ConclusionPatients with high HDL cholesterol were found to be physically more active, had a lower BMI, a lower triglyceride level, and a lower ASCVD risk compared with controls. They also had a lower CETP level. Further research will be required to determine the normal CETP level in Indian population, their genetic makeup, and whether it has a role in cardiovascular protection.
引用
收藏
页码:537 / 544
页数:8
相关论文
共 50 条
[41]   Thrombospondin-4 polymorphism (A387P) predicts cardiovascular risk in postinfarction patients with high HDL cholesterol and C-reactive protein levels [J].
Corsetti, James P. ;
Ryan, Dan ;
Moss, Arthur J. ;
McCarthy, Jeanette J. ;
Goldenberg, Ilan ;
Zareba, Wojciech ;
Sparks, Charles E. .
THROMBOSIS AND HAEMOSTASIS, 2011, 106 (06) :1170-1178
[42]   The Evolving Role of HDL in the Treatment of High-Risk Patients with Cardiovascular Disease [J].
Brewer, H. Bryan, Jr. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (05) :1246-1257
[43]   Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk [J].
Rosenblit, Paul D. .
CURRENT DIABETES REPORTS, 2019, 19 (12)
[44]   The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk [J].
Sandesara, Pratik B. ;
Virani, Salim S. ;
Fazio, Sergio ;
Shapiro, Michael D. .
ENDOCRINE REVIEWS, 2019, 40 (02) :537-557
[45]   Atherosclerotic cardiovascular disease risk based on SCORE algorithms and reclassification based on preclinical atherosclerotic plaques [J].
Nicolaides, Andrew N. ;
Panayiotou, Andrie G. ;
Griffin, Maura B. ;
Tyllis, Theodosis ;
Kyriacou, Efthyvoulos ;
Avraamides, Costantinos ;
Bond, Dawn ;
Georgiou, Niki ;
Ierodiakonou, Despo ;
Demetriou, Christiana A. ;
Martin, Richard M. .
INTERNATIONAL ANGIOLOGY, 2024, 43 (05) :519-532
[46]   Improved HDL Cholesterol through Vitamin D Status Correction Substantially Lowers 10-Year Atherosclerotic Cardiovascular Disease Risk Score in Vitamin D-Deficient Arab Adults [J].
Sabico, Shaun ;
Wani, Kaiser ;
Grant, William B. B. ;
Al-Daghri, Nasser M. M. .
NUTRIENTS, 2023, 15 (03)
[47]   Adjustment of the SMART risk score by bioactive adrenomedullin enables a more accurate prediction of mortality in patients with ASCVD [J].
Kurt, Berkan ;
Rau, Matthias ;
Hartmann, Oliver ;
Bergmann, Andreas ;
Reugels, Martin ;
Just, Susanne ;
Wenzl, Florian A. ;
Moellmann, Julia ;
Spiesshoefer, Jens ;
Milzi, Andrea ;
Kneizeh, Kinan ;
Thiele, Kirsten ;
Hohl, Mathias ;
Selejan, Simina-Ramona ;
van der Vorst, Emiel P. C. ;
Dahl, Edgar ;
Schroder, Jorg ;
Luscher, Thomas F. ;
Marx, Nikolaus ;
Lehrke, Michael ;
Kahles, Florian .
ATHEROSCLEROSIS, 2025, 406
[48]   The Effects of Intensive Blood Pressure Control on Cardiovascular Outcomes Based on 10-Year ASCVD Risk Score: An Analysis of a Clinical Trial [J].
Alborzi, Alireza ;
Attar, Armin ;
Sayadi, Mehrab ;
Nouri, Fatemeh .
CARDIOLOGY RESEARCH AND PRACTICE, 2021, 2021
[49]   Risk of nosocomial infections and effects of total cholesterol, HDL cholesterol in surgical patients [J].
Canturk, NZ ;
Canturk, Z ;
Okay, E ;
Yirmibesoglu, O ;
Eraldemir, B .
CLINICAL NUTRITION, 2002, 21 (05) :431-436
[50]   Polygenic risk score adds to a clinical risk score in the prediction of cardiovascular disease in a clinical setting [J].
Samani, Nilesh J. ;
Beeston, Emma ;
Greengrass, Chris ;
Riveros-McKay, Fernando ;
Debiec, Radoslaw ;
Lawday, Daniel ;
Wang, Qingning ;
Budgeon, Charley A. ;
Braund, Peter S. ;
Bramley, Richard ;
Kharodia, Shireen ;
Newton, Michelle ;
Marshall, Andrea ;
Krzeminski, Andre ;
Zafar, Azhar ;
Chahal, Anuj ;
Heer, Amadeeep ;
Khunti, Kamlesh ;
Joshi, Nitin ;
Lakhani, Mayur ;
Farooqi, Azhar ;
Plagnol, Vincent ;
Donnelly, Peter ;
Weale, Michael E. ;
Nelson, Christopher P. .
EUROPEAN HEART JOURNAL, 2024, 45 (34) :3152-3160